How Dr. Barba helped a lifelong runner get back on the road.

By the time he scheduled his first visit at LAOSS, our patient had been running for nearly three decades. He had a closet full of finisher medals from half-marathons, a regular Saturday-morning training group, and a knee that had quietly started complaining about every one of those miles. The pain was deep and medial — inside the joint — and it was worst the morning after a long run. It felt fine, mostly, on rest days. He told us he'd been managing with ibuprofen, ice, and "just slowing down," but the slowing down kept needing to be more.

His first imaging — taken at an urgent care eight months earlier — had shown what the records called "mild osteoarthritis." By the time we saw him on weight-bearing X-rays, the medial joint space had narrowed further and the subchondral bone was starting to look the part. Clinically, he had a small effusion, a clear varus alignment, and reproducible joint-line pain. The history, the exam, and the imaging all said the same thing — early-to-moderate knee OA, asymmetric on the medial side, in someone whose joint had given him decades of high-impact loading and was finally asking to renegotiate.

We never lead with replacement on a fifty-something patient with mild-to-moderate OA, and we didn't here. The first step was a twelve-week course of physical therapy focused on quadriceps strength, hip abductor strength, gait retraining, and a graded transition off pavement onto softer surfaces. He was also a candidate for modest weight reduction — every pound off the knee is roughly four pounds off the joint at heel strike, and that math is the cheapest mechanical intervention in orthopedics. He dropped fifteen pounds over four months and reported a real difference.

When pain persisted on longer runs, we added a low-profile unloader brace for training and tried a hyaluronic acid (viscosupplementation) injection series. He got roughly six months of meaningful relief — enough to finish one more half-marathon, which mattered to him. When the relief faded, we tried a single corticosteroid injection. The benefit was modest and short. At that point we sat down together and laid out the full menu — keep alternating injections, modify activity further, or plan a replacement. The decision was his. He told us he was tired of managing the knee and that he'd rather have it fixed than negotiated with for another five years.

By the time the conversation turned surgical, three things were true. The medial compartment was bone-on-bone on standing imaging, the symptoms were no longer controlled between injections, and his goals were specific and articulable — return to short recreational runs and pain-free hiking with his family. Robotic-assisted total knee replacement gives us pre-operative planning based on a CT-derived model of the patient's own anatomy and intra-operative guidance that protects soft tissues and improves component alignment, which is one of the few intra-operative variables strongly tied to long-term implant survival.

We also had an honest conversation about what running would and would not look like on a replaced knee. Modern bearing surfaces tolerate recreational running better than they did fifteen years ago, but a return to marathon-distance training is a separate question with separate risk. He understood and agreed before we ever scheduled the operation.

A full marathon return was not realistic for this patient and we said so before he ever signed a consent form. The published return-to-running data for total knee patients support short-to-medium distances at moderate frequency on softer surfaces — not 26.2 miles. He has adjusted to that ceiling and reports it doesn't bother him; he runs three to four miles, two or three days a week, mostly on the trail. He still cycles. He still hikes. He no longer manages a knee — and that, for him, was the win. It's worth saying: not every patient is comfortable making that kind of trade. The right time to find out is before surgery, not after.

Composite case based on common LAOSS treatment outcomes. Anonymized for patient privacy.